Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.

Motohashi K, Suzuki T, Kishimoto K, Numata A, Nakajima Y, Tachibana T, Ohshima R, Kuwabara H, Tanaka M, Tomita N, Ishigatsubo Y, Fujisawa S.

Int J Hematol. 2013 Aug;98(2):258-60. doi: 10.1007/s12185-013-1387-8. Epub 2013 Jun 26.

PMID:
23801427
2.

The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.

Kawano N, Kuriyama T, Yoshida S, Kawano S, Yamano Y, Marutsuka K, Minato S, Yamashita K, Ochiai H, Shimoda K, Ishikawa F, Kikuchi I.

J Clin Exp Hematop. 2017;56(3):135-144. doi: 10.3960/jslrt.56.135.

3.

Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.

Sugio T, Kato K, Aoki T, Ohta T, Saito N, Yoshida S, Kawano I, Henzan H, Kadowaki M, Takase K, Muta T, Miyawaki K, Yamauchi T, Shima T, Takashima S, Mori Y, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Ogawa R, Ohno Y, Eto T, Kamimura T, Miyamoto T, Akashi K.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1608-1614. doi: 10.1016/j.bbmt.2016.05.017. Epub 2016 May 21.

4.

Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.

Tsubokura Y, Satake A, Hotta M, Yoshimura H, Fujita S, Azuma Y, Nakanishi T, Nakaya A, Ito T, Ishii K, Nomura S.

Int J Hematol. 2016 Dec;104(6):744-748. Epub 2016 Aug 29.

PMID:
27573760
5.

Successful umbilical cord blood hematopoietic stem cell transplantation in a patient with adult T-cell leukemia/lymphoma initially achieving complete remission with anti-CC chemokine receptor 4 antibody combined chemotherapy.

Suwabe T, Shibasaki Y, Kaihatsu A, Katagiri T, Miyakoshi S, Fuse K, Kobayashi H, Ushiki T, Moriyama M, Takizawa J, Narita M, Sone H, Masuko M.

Rinsho Ketsueki. 2017;58(1):32-36. doi: 10.11406/rinketsu.58.32. Japanese.

PMID:
28190863
6.

Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality.

Fuji S, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Choi I, Otsuka E, Henzan H, Kato K, Tomoyose T, Yamamoto H, Kurosawa S, Matsuoka K, Yamaguchi T, Fukuda T.

J Clin Oncol. 2016 Oct 1;34(28):3426-33. doi: 10.1200/JCO.2016.67.8250. Epub 2016 Aug 9.

PMID:
27507878
7.

Persistent complete remission of acute leukemic-phase CCR4-positive gamma-delta peripheral T-cell lymphoma by autologous stem cell transplantation with mogamulizumab.

Furukawa M, Ikeda K, Ohkawara H, Saito S, Takahashi H, Ueda K, Matsumoto H, Hashimoto Y, Ohto H, Ogawa K, Takeishi Y.

Int J Hematol. 2015 Oct;102(4):498-505. doi: 10.1007/s12185-015-1805-1. Epub 2015 May 15. Erratum in: Int J Hematol. 2015 Jul;102(1):147. Udea, Koki [corrected to Ueda, Koki].

PMID:
25975265
8.

Administration of an anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab, before allogeneic bone marrow transplantation for adult T-cell leukemia/lymphoma.

Haji S, Kiyasu J, Choi I, Suehiro Y, Toyoda K, Tsuda M, Takamatsu A, Nakashima Y, Miyoshi H, Shiratsuchi M, Yamasaki S, Uike N, Abe Y.

Bone Marrow Transplant. 2016 Mar;51(3):432-4. doi: 10.1038/bmt.2015.254. Epub 2015 Nov 2. No abstract available.

PMID:
26524267
9.

Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.

Winsett FT, Lewis DJ, Duvic M.

Expert Rev Hematol. 2017 Sep;10(9):757-760. doi: 10.1080/17474086.2017.1361819. Epub 2017 Aug 21. Review.

PMID:
28756726
10.

A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.

Iyama S, Sato T, Ohnishi H, Kanisawa Y, Ohta S, Kondo T, Mori A, Tsutsumi Y, Kuroda H, Kakinoki Y, Yamamoto S, Takahashi T, Shindo M, Torimoto Y, Sato K, Iwasaki H, Haseyama Y, Kohda K, Nagamachi Y, Hirayama Y, Sakai H, Hirata Y, Fukuhara T, Ikeda H, Kobune M, Kato J, Kurosawa M.

Clin Lymphoma Myeloma Leuk. 2017 Jan;17(1):23-30.e2. doi: 10.1016/j.clml.2016.09.009. Epub 2016 Sep 17.

PMID:
27727135
11.

[Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].

Kawashima I, Sueki Y, Yamamoto T, Nozaki Y, Nakajima K, Mitsumori T, Kirito K.

Rinsho Ketsueki. 2015 Feb;56(2):210-5. doi: 10.11406/rinketsu.56.210. Japanese.

PMID:
25765802
12.

A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.

Kawada H, Yoshimitsu M, Nakamura D, Arai A, Hayashida M, Kamada Y, Maekawa K, Fujino S, Arima M, Arima N, Tabuchi T, Inoue H, Hamda H, Suzuki S, Matsushita K, Arima N.

Biol Blood Marrow Transplant. 2015 Apr;21(4):696-700. doi: 10.1016/j.bbmt.2014.12.020. Epub 2014 Dec 24.

13.

Haploidentical transplantation using post-transplant high-dose cyclophosphamide for adult T-cell lymphoma after mogamulizumab treatment.

Kusakabe M, Kurita N, Nishikii H, Sato R, Yoshida C, Yokoyama Y, Sakata-Yanagimoto M, Obara N, Hasegawa Y, Chiba S.

Rinsho Ketsueki. 2017;58(5):449-454. doi: 10.11406/rinketsu.58.449. Review. Japanese.

PMID:
28592758
14.

Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma.

Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M, Tanosaki R, Utsunomiya A, Uike N, Yoshida S, Okamura J, Tomonaga M.

Leukemia. 2005 May;19(5):829-34.

PMID:
15744352
15.

Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation.

Kamimura T, Miyamoto T, Kawano N, Numata A, Ito Y, Chong Y, Nagafuji K, Teshima T, Hayashi S, Akashi K.

Int J Hematol. 2012 Jun;95(6):725-30. doi: 10.1007/s12185-012-1056-3. Epub 2012 Apr 6.

PMID:
22481502
16.

Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis.

Yonekura K, Kanzaki T, Gunshin K, Kawakami N, Takatsuka Y, Nakano N, Tokunaga M, Kubota A, Takeuchi S, Kanekura T, Utsunomiya A.

J Dermatol. 2014 Mar;41(3):239-44. doi: 10.1111/1346-8138.12419.

PMID:
24628073
17.

Recent Advances in Therapeutic Approaches for Adult T-cell Leukemia/Lymphoma.

Kato K, Akashi K.

Viruses. 2015 Dec 14;7(12):6604-12. doi: 10.3390/v7122960. Review.

18.

Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice.

Sekine M, Kubuki Y, Kameda T, Takeuchi M, Toyama T, Kawano N, Maeda K, Sato S, Ishizaki J, Kawano H, Kamiunten A, Akizuki K, Tahira Y, Shimoda H, Shide K, Hidaka T, Kitanaka A, Yamashita K, Matsuoka H, Shimoda K.

Eur J Haematol. 2017 May;98(5):501-507. doi: 10.1111/ejh.12863. Epub 2017 Mar 10.

PMID:
28152225
19.

Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab.

Ishitsuka K, Murahashi M, Katsuya H, Mogi A, Masaki M, Kawai C, Goto T, Ishizu M, Ikari Y, Takamatsu Y, Ishibashi H, Nimura S, Takeshita M, Tamura K.

Int J Hematol. 2015 Oct;102(4):493-7. doi: 10.1007/s12185-015-1811-3. Epub 2015 May 21.

PMID:
25995001
20.

Supplemental Content

Support Center